The global organoids and spheroids market was valued at $516.56 million in 2021 and is projected to reach $1,179.96 million by 2031, registering a CAGR of 8.5% from 2022 to 2031. Organoids are 3D cell cultures most frequently grown on a scaffold-based system. Organoids are normally derived from a single adult stem cell or embryonic stem cell. They can also be produced from induced pluripotent stem cells such as skin or blood cells. Spheroids are 3D cell cultures that are grown on a scaffold-free system. They consist of cell aggregates generated from a single cell type or from a multicellular mixture of cells. Spheroids can be established from immortalized cell lines, primary cells, or fragments of human tissue.
The key factors that drive the growth of the market are an increase in the adoption of personalized medicines, growth in investments toward R&D activities and a shift in preference toward organoids 3D cell cultures for cancer research are the major factors that boost the growth of the organoids and spheroids market. Moreover, an increase in product development by pharma & biotech companies propels the growth of the market. For instance, Corning Incorporated launched HTS Transwell tissue culture systems and spheroid microplates for high-throughput culturing, which will help in cell tissue culturing and help in the development of cell-based therapies or personalized medicines.
However, higher implementation cost hampers the market growth. Conversely, technological advancements and emerging healthcare market in developing countries is expected to provide a lucrative opportunity during the forecast period.
The organoids and spheroid market are segmented on the basis of type, method, end user, and region. By type, it is segmented into organoids and spheroids. On the basis of method, it is segmented into extracellular matrix scaffold method, spinning bioreactor method, hanging drop method, low adherent culture plate method, magnetic levitation method, and others. By end user, it is segmented into biotechnology and pharmaceutical industries, academic & research institutes, hospitals, and diagnostic centers. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the organoids and spheroid market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the increase in the healthcare expenditure of this region and the presence of significant players in the country and the strategies they adopt for their product development.
Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period, owing to a rise in the prevalence of cancer and an increase in demand of cell tissue culturing techniques.
The key players that operate in the organoids and spheroid market are AMS Biotechnology Limited, ATCC, 3D Biotek LLC, 3Dnamics Inc., Cellesce Ltd., Corning Inc, DefiniGEN Ltd, Greiner AG, Hubrecht Organoid Technology, InSphero AG, Lonza, Merck KGaA, PeproTech Inc., Perkin Elmer Inc, Prellis Biologics, STEMCELL Technologies Inc. and Thermofisher Scientific Inc.
The key factors that drive the growth of the market are an increase in the adoption of personalized medicines, growth in investments toward R&D activities and a shift in preference toward organoids 3D cell cultures for cancer research are the major factors that boost the growth of the organoids and spheroids market. Moreover, an increase in product development by pharma & biotech companies propels the growth of the market. For instance, Corning Incorporated launched HTS Transwell tissue culture systems and spheroid microplates for high-throughput culturing, which will help in cell tissue culturing and help in the development of cell-based therapies or personalized medicines.
However, higher implementation cost hampers the market growth. Conversely, technological advancements and emerging healthcare market in developing countries is expected to provide a lucrative opportunity during the forecast period.
The organoids and spheroid market are segmented on the basis of type, method, end user, and region. By type, it is segmented into organoids and spheroids. On the basis of method, it is segmented into extracellular matrix scaffold method, spinning bioreactor method, hanging drop method, low adherent culture plate method, magnetic levitation method, and others. By end user, it is segmented into biotechnology and pharmaceutical industries, academic & research institutes, hospitals, and diagnostic centers. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the organoids and spheroid market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the increase in the healthcare expenditure of this region and the presence of significant players in the country and the strategies they adopt for their product development.
Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period, owing to a rise in the prevalence of cancer and an increase in demand of cell tissue culturing techniques.
The key players that operate in the organoids and spheroid market are AMS Biotechnology Limited, ATCC, 3D Biotek LLC, 3Dnamics Inc., Cellesce Ltd., Corning Inc, DefiniGEN Ltd, Greiner AG, Hubrecht Organoid Technology, InSphero AG, Lonza, Merck KGaA, PeproTech Inc., Perkin Elmer Inc, Prellis Biologics, STEMCELL Technologies Inc. and Thermofisher Scientific Inc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the organoids and spheroids market analysis from 2021 to 2031 to identify the prevailing organoids and spheroids market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the organoids and spheroids market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global organoids and spheroids market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Organoids
- Type
- Neural Organoids
- Hepatic Organoids
- Intestinal Organoids
- Others
- Spheroids
- Type
- Multicellular Tumor spheroids
- Neurospheres
- Mammospheres
- Hepatospheres
By Method
- Others
- Extracellular Matrix scaffold Method
- Spinning Boireactor method
- Hanging Drop method
- Low adherent Culture plate method
- Magnetic leviation Method
By End User
- Biotechnology and Pharmaceutical Industry
- Academic and Research Institutes
- Hospitals and Diagnostic Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ATCC
- 3D Biotek LLC
- 3Dnamics Inc
- Cellesce Ltd
- Corning Inc
- DefiniGEN Ltd
- Greiner AG
- Hubrecht Organoid Technology
- InSphero AG
- Lonza
- Merck KGaA
- PeproTech Inc.
- Perkin Elmer Inc
- Prellis Biologics
- STEMCELL Technologies Inc
- Thermofisher Scientific Inc
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE
CHAPTER 5: ORGANOIDS AND SPHEROIDS MARKET, BY METHOD
CHAPTER 6: ORGANOIDS AND SPHEROIDS MARKET, BY END USER
CHAPTER 7: ORGANOIDS AND SPHEROIDS MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Organoids and Spheroids Market," the Organoids and Spheroids Market size was valued at $516.56 million in 2021, and is estimated to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031.Organoids and spheroids are two types of 3D cell cultures. which is a cluster of biological cells grown in an artificially created environment. These biological cells are permitted to grow or interact with their surroundings in all three dimensions.
The Organoids and Spheroids Market trends are an increase in the adoption of personalized medicines, growth in investments toward R&D activities, and a shift in preference toward organoids 3D cell cultures for cancer research are the major factors that boost the Organoids and Spheroids Market growth. In addition, the rise in technological advancement in 3D spheroids technologies in developing countries such as China, Japan, and India would propel the growth of the organoids and spheroid industry. However, the high cost of implementation hampers the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide a lucrative opportunity during the forecast period.
On the basis of type, the Organoids and Spheroids Market are segmented into organoids and spheroids. In 2021, the organoids segment accounted for the largest share of the market. The dominance of this segment can be attributed to rise in the adoption of organoids in various applications such as disease modeling, pathogenesis, drug screening, and regenerative medicine.
On the basis of method, it is segmented into extracellular matrix scaffold method, spinning bioreactor method, hanging drop method, low adherent culture plate method, magnetic levitation method, and others, the extracellular matrix scaffold method segment exhibited the Organoids and Spheroids Market share in 2021, and is anticipated to lead during the forecast period.
By end user it is segmented into biotechnology and pharmaceutical industries, academic & research institutes, hospitals, and diagnostic centers, the biotechnology and pharmaceutical industries segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period, owing to increased use of organoids for biopharmaceuticals and cancer drug research are the key factors that drive the growth of the market in upcoming years.
North America accounted for a majority of the organoids and spheroid market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the presence of several pharmaceutical and biotechnology companies that use 3D culture technology in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development.
Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period, due to economic development and low operating costs. Moreover, the rising focus in biopharmaceutical R&D, the huge production of drugs, and the surge in the prevalence of cancer are also propelling the growth of the market in this region.
The key players that operate in the Organoids and Spheroids Industryare AMS Biotechnology Limited, ATCC, 3D Biotek LLC, 3Dnamics Inc., Cellesce Ltd., Corning Inc, DefiniGEN Ltd, Greiner AG, Hubrecht Organoid Technology, InSphero AG, Lonza, Merck KGaA, PeproTech Inc., Perkin Elmer Inc, Prellis Biologics, STEMCELL Technologies Inc. and Thermofisher Scientific Inc.
Key Findings of the Study
- By type, the organoids segment was the highest contributor to the market in 2021.
- By method, the extracellular matrix scaffold method segment was the highest contributor to the market in 2021.
- By end user, the biotechnology and pharmaceutical industries segment is projected to grow at a significant CAGR of 9.0% from 2022 to 2031.
- By region, North America garnered largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 9.5% during the review period.
Companies Mentioned
- Atcc
- 3D Biotek LLC
- 3Dnamics Inc
- Cellesce Ltd
- Corning Inc
- Definigen Ltd
- Greiner AG
- Hubrecht Organoid Technology
- Insphero AG
- Lonza
- Merck Kgaa
- Peprotech Inc.
- Perkin Elmer Inc
- Prellis Biologics
- Stemcell Technologies Inc
- Thermofisher Scientific Inc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 315 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 516.56 million |
| Forecasted Market Value ( USD | $ 1179.96 million |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
